We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MoneyGram Partners Ebix to Offer Inward Remittance in India
Read MoreHide Full Article
MoneyGram International, Inc. has tied up with Ebix, Inc. , a leading international supplier of On-Demand software and e-commerce services.
Per the agreement, Ebix’s wholly-owned subsidiary, EbixCash will be the exclusive partner of MoneyGram in India. Its customers will be able to reach out to MoneyGram to seamlessly receive money from family and friends around the world.
Ebix’s huge presence in India makes it a perfect fit for MoneyGram. Ebix has 320,000 distribution outlets spread across 768 districts, 4,000 cities, and more than 75,000 villages, giving it a significant presence in rural India.
Per the deal, MoneyGram will be handling inward remittances to India. The country is expected to see inward remittances of $3 billion annually. This makes India the leading remittance-receiving country in Asia and an attractive market for MoneyGram.
This move also reflects MoneyGram’s strategy to expand its international operations at a time when revenue growth in the United States is difficult to achieve, given intense competition from new fintech players such as TransferWise, Azimo, Remitly and WorldRemit, to name a few.
These companies utilize online and mobile platforms to transfer money, which makes their services more cost-effective and efficient. Unlike MoneyGram, which has to pay a commission to brick-and-mortar agents that originate the transfers, most of the players steer clear of the same, because of their use of digital channels. This helps them save a large chunk of operating cost and enables them to enjoy better operating margins.
It is to be noted that revenues from MoneyGram’s U.S. operations declined by 1.4% and 13% in 2017 and 2018, respectively. Over the past two years, its market capitalization has eroded by nearly 72%.
The stock has lost 8.5% against the industry’s growth of 16.5% in the past year. This performance pales in comparison with the price gains of 5.3% for Square, 51.4% for Western Union Co. (WU - Free Report) and 27.5% for PayPal Holdings, Inc. (PYPL - Free Report) .
MoneyGram is making continuous investments to develop its digital platforms. Notably, the company witnessed a record-breaking online transaction growth during the most recent holiday shopping season.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
MoneyGram Partners Ebix to Offer Inward Remittance in India
MoneyGram International, Inc. has tied up with Ebix, Inc. , a leading international supplier of On-Demand software and e-commerce services.
Per the agreement, Ebix’s wholly-owned subsidiary, EbixCash will be the exclusive partner of MoneyGram in India. Its customers will be able to reach out to MoneyGram to seamlessly receive money from family and friends around the world.
Ebix’s huge presence in India makes it a perfect fit for MoneyGram. Ebix has 320,000 distribution outlets spread across 768 districts, 4,000 cities, and more than 75,000 villages, giving it a significant presence in rural India.
Per the deal, MoneyGram will be handling inward remittances to India. The country is expected to see inward remittances of $3 billion annually. This makes India the leading remittance-receiving country in Asia and an attractive market for MoneyGram.
This move also reflects MoneyGram’s strategy to expand its international operations at a time when revenue growth in the United States is difficult to achieve, given intense competition from new fintech players such as TransferWise, Azimo, Remitly and WorldRemit, to name a few.
These companies utilize online and mobile platforms to transfer money, which makes their services more cost-effective and efficient. Unlike MoneyGram, which has to pay a commission to brick-and-mortar agents that originate the transfers, most of the players steer clear of the same, because of their use of digital channels. This helps them save a large chunk of operating cost and enables them to enjoy better operating margins.
It is to be noted that revenues from MoneyGram’s U.S. operations declined by 1.4% and 13% in 2017 and 2018, respectively. Over the past two years, its market capitalization has eroded by nearly 72%.
The stock has lost 8.5% against the industry’s growth of 16.5% in the past year. This performance pales in comparison with the price gains of 5.3% for Square, 51.4% for Western Union Co. (WU - Free Report) and 27.5% for PayPal Holdings, Inc. (PYPL - Free Report) .
MoneyGram is making continuous investments to develop its digital platforms. Notably, the company witnessed a record-breaking online transaction growth during the most recent holiday shopping season.
MoneyGram carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>